Literature DB >> 29679170

Light localization with low-contrast targets in a patient implanted with a suprachoroidal-transretinal stimulation retinal prosthesis.

Takao Endo1, Takashi Fujikado2, Masakazu Hirota2, Hiroyuki Kanda2, Takeshi Morimoto3, Kohji Nishida1.   

Abstract

PURPOSE: To evaluate the improvement in targeted reaching movements toward targets of various contrasts in a patient implanted with a suprachoroidal-transretinal stimulation (STS) retinal prosthesis.
METHODS: An STS retinal prosthesis was implanted in the right eye of a 42-year-old man with advanced Stargardt disease (visual acuity: right eye, light perception; left eye, hand motion). In localization tests during the 1-year follow-up period, the patient attempted to touch the center of a white square target (visual angle, 10°; contrast, 96, 85, or 74%) displayed at a random position on a monitor. The distance between the touched point and the center of the target (the absolute deviation) was averaged over 20 trials with the STS system on or off.
RESULTS: With the left eye occluded, the absolute deviation was not consistently lower with the system on than off for high-contrast (96%) targets, but was consistently lower with the system on for low-contrast (74%) targets. With both eyes open, the absolute deviation was consistently lower with the system on than off for 85%-contrast targets. With the system on and 96%-contrast targets, we detected a shorter response time while covering the right eye, which was being implanted with the STS, compared to covering the left eye (2.41 ± 2.52 vs 8.45 ± 3.78 s, p < 0.01).
CONCLUSIONS: Performance of a reaching movement improved in a patient with an STS retinal prosthesis implanted in an eye with residual natural vision. Patients with a retinal prosthesis may be able to improve their visual performance by using both artificial vision and their residual natural vision. CLINICAL TRIAL REGISTRATION: Beginning date of the trial: Feb. 20, 2014 Date of registration: Jan. 4, 2014 Trial registration number: UMIN000012754 Registration site: UMIN Clinical Trials Registry (UMIN-CTR) http://www.umin.ac.jp/ctr/index.htm.

Entities:  

Keywords:  Contrast of a target; Localization test; Retinal prosthesis; Suprachoroidal–transretinal stimulation; Targeted reaching movement; Ultra-low vision

Mesh:

Year:  2018        PMID: 29679170     DOI: 10.1007/s00417-018-3982-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

Review 1.  Will retinal implants restore vision?

Authors:  Eberhart Zrenner
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

2.  Evaluation of stimulus parameters and electrode geometry for an effective suprachoroidal retinal prosthesis.

Authors:  Mohit N Shivdasani; Chi D Luu; Rosemary Cicione; James B Fallon; Penny J Allen; James Leuenberger; Gregg J Suaning; Nigel H Lovell; Robert K Shepherd; Chris E Williams
Journal:  J Neural Eng       Date:  2010-05-18       Impact factor: 5.379

3.  False reaching movements in localization test and effect of auditory feedback in simulated ultra-low vision subjects and patients with retinitis pigmentosa.

Authors:  Takao Endo; Hiroyuki Kanda; Masakazu Hirota; Takeshi Morimoto; Kohji Nishida; Takashi Fujikado
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-07       Impact factor: 3.117

4.  Focal activation of the feline retina via a suprachoroidal electrode array.

Authors:  Y T Wong; S C Chen; J M Seo; J W Morley; N H Lovell; G J Suaning
Journal:  Vision Res       Date:  2009-03-09       Impact factor: 1.886

5.  Performance of photovoltaic arrays in-vivo and characteristics of prosthetic vision in animals with retinal degeneration.

Authors:  Henri Lorach; Georges Goetz; Yossi Mandel; Xin Lei; Ludwig Galambos; Theodore I Kamins; Keith Mathieson; Philip Huie; Roopa Dalal; James S Harris; Daniel Palanker
Journal:  Vision Res       Date:  2014-09-26       Impact factor: 1.886

6.  How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation.

Authors:  Sheila K West; Gary S Rubin; Aimee T Broman; Beatriz Muñoz; Karen Bandeen-Roche; Kathleen Turano
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Spatial localization in visual impairment.

Authors:  Ahalya Subramanian; Christine Dickinson
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

8.  FLORA™: Phase I development of a functional vision assessment for prosthetic vision users.

Authors:  Duane R Geruschat; Marshall Flax; Nilima Tanna; Michelle Bianchi; Andy Fisher; Mira Goldschmidt; Lynne Fisher; Gislin Dagnelie; Jim Deremeik; Audrey Smith; Fatima Anaflous; Jessy Dorn
Journal:  Clin Exp Optom       Date:  2015-02-11       Impact factor: 2.742

9.  Cochlear implantation with hearing preservation yields significant benefit for speech recognition in complex listening environments.

Authors:  René H Gifford; Michael F Dorman; Henryk Skarzynski; Artur Lorens; Marek Polak; Colin L W Driscoll; Peter Roland; Craig A Buchman
Journal:  Ear Hear       Date:  2013 Jul-Aug       Impact factor: 3.570

10.  Saliency-based image processing for retinal prostheses.

Authors:  N Parikh; L Itti; J Weiland
Journal:  J Neural Eng       Date:  2010-01-14       Impact factor: 5.379

View more
  3 in total

Review 1.  Retinal Prosthetic Approaches to Enhance Visual Perception for Blind Patients.

Authors:  Shinyong Shim; Kyungsik Eom; Joonsoo Jeong; Sung June Kim
Journal:  Micromachines (Basel)       Date:  2020-05-24       Impact factor: 2.891

Review 2.  Advances in retinal prosthesis systems.

Authors:  Edward Bloch; Yvonne Luo; Lyndon da Cruz
Journal:  Ther Adv Ophthalmol       Date:  2019-01-17

3.  Testing of Newly Developed Wide-Field Dual-Array Suprachoroidal-Transretinal Stimulation Prosthesis in Dogs.

Authors:  Takeshi Morimoto; Takashi Fujikado; Hiroyuki Kanda; Tomomitsu Miyoshi; Takao Endo; Kentaro Nishida; Haruhiko Kishima; Toru Saito; Kunihiko Ito; Motoki Ozawa; Kohji Nishida
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.